Premiplex (mecasermin rinfabate) - Oak Hill Bio, Chiesi
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants (clinicaltrials.gov) - Jun 12, 2026 - P2 | N=338 | Recruiting | Sponsor: OHB Neonatology Ltd. | Trial primary completion date: Jan 2026 ➔ Jul 2026 
Trial primary completion date • Bronchopulmonary Dysplasia • Hematological Disorders • Pulmonary Disease • Respiratory Diseases • Retinal Disorders • Retinopathy of Prematurity • IGF1
http://clinicaltrials.gov/ct2/show/NCT03253263
 
Jun 12, 2026
 
Prev Next